Meridian Bioscience Inc financial data

Industry
In Vitro & In Vivo Diagnostic Substances
Location
3471 River Hills Dr, Cincinnati, OH
State of incorporation
OH
Fiscal year end
September 30
Former names
MERIDIAN DIAGNOSTICS INC (to 2/12/2001)
Latest financial report
10-Q - Q4 2022 - Feb 9, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 332 % -21.5%
Quick Ratio 111 % -30.7%
Return On Assets -0.58 % -104%
Operating Margin 1.99 % -92.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44M shares +1.07%
Common Stock, Shares, Outstanding 43.8M shares +0.55%
Entity Public Float 1.12B USD -0.68%
Weighted Average Number of Shares Outstanding, Basic 43.9M shares +1.05%
Weighted Average Number of Shares Outstanding, Diluted 43.9M shares -0.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 302M USD -3.75%
Revenue from Contract with Customer, Excluding Assessed Tax 302M USD -3.75%
Research and Development Expense 24.3M USD -0.56%
Selling and Marketing Expense 31.8M USD +15.7%
General and Administrative Expense 53.6M USD +2.48%
Operating Income (Loss) 5.99M USD -92.4%
Nonoperating Income (Expense) -524K USD +80.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 5.47M USD -92.8%
Income Tax Expense (Benefit) 8.17M USD -48.9%
Net Income (Loss) Attributable to Parent -2.7M USD -105%
Earnings Per Share, Basic -0.06 USD/shares -104%
Earnings Per Share, Diluted -0.07 USD/shares -105%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 74.1M USD +1.88%
Inventory, Net 72.7M USD -2.07%
Assets, Current 202M USD -1.04%
Deferred Income Tax Assets, Net 9.65M USD +9.5%
Property, Plant and Equipment, Net 45.4M USD +4.93%
Operating Lease, Right-of-Use Asset 6.04M USD +11.2%
Intangible Assets, Net (Excluding Goodwill) 71.6M USD -12.4%
Goodwill 121M USD +5.1%
Assets 457M USD -0.41%
Accounts Payable, Current 14.4M USD -11.5%
Employee-related Liabilities, Current 9.89M USD -17.7%
Accrued Liabilities, Current 6.29M USD -27.4%
Liabilities, Current 78.6M USD +57.3%
Accrued Income Taxes, Noncurrent 395K USD -15.8%
Deferred Income Tax Liabilities, Net 1.1M USD -46.6%
Operating Lease, Liability, Noncurrent 4.19M USD +18.6%
Other Liabilities, Noncurrent 712K USD +312%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.07M USD -1375%
Retained Earnings (Accumulated Deficit) 193M USD -1.38%
Stockholders' Equity Attributable to Parent 341M USD -1.36%
Liabilities and Equity 457M USD -0.41%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.35M USD -107%
Net Cash Provided by (Used in) Financing Activities -2.52M USD +77.2%
Net Cash Provided by (Used in) Investing Activities -4.65M USD -172%
Common Stock, Shares Authorized 71M shares 0%
Common Stock, Shares, Issued 44M shares +1.12%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.36M USD -132%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 74.1M USD +1.88%
Deferred Tax Assets, Valuation Allowance 1.43M USD -12.1%
Deferred Tax Assets, Gross 22.8M USD +3.94%
Operating Lease, Liability 6.14M USD -20.4%
Depreciation 1.64M USD -3.35%
Payments to Acquire Property, Plant, and Equipment 2.65M USD +55.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.3M USD -117%
Lessee, Operating Lease, Liability, to be Paid 6.36M USD -23.2%
Property, Plant and Equipment, Gross 126M USD +2.17%
Operating Lease, Liability, Current 1.95M USD -5.01%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.52M USD -14.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.8M USD -17.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 216K USD -76.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 222K USD -61.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 796K USD -46%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 774K USD +10.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 545K USD -38.8%
Operating Lease, Payments 580K USD -7.5%
Amortization of Intangible Assets 9.97M USD +10.3%
Deferred Tax Assets, Net of Valuation Allowance 21.4M USD +5.22%
Operating Leases, Future Minimum Payments, Due in Three Years 1.11M USD -36.9%
Interest Expense 965K USD -43.8%